HLB Pharmaceutical has newly appeared among the top searched stocks.


As of 12:30 PM on the 15th, HLB Pharmaceutical is trading at 16,850 KRW, down 3.71% from the previous day. This represents a 13.09% increase compared to January 28. HLB Pharmaceutical is known as a finished pharmaceutical company utilizing peptides.

Over the past five days, individual investors have sold a net 90,630 shares, while foreigners and institutions have bought a net 87,843 shares and 32,116 shares, respectively.


On February 9, HLB Pharmaceutical was an issue in the market with the headline, "HLB Pharmaceutical rises on news of Russia's COVID-19 vaccine review... past..."



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing